Press releases
- Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
- Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
- Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
More ▼
Key statistics
On Friday, Enanta Pharmaceuticals Inc (9EP:MUN) closed at 11.80, 53.25% above the 52 week low of 7.70 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.80 |
---|---|
High | 11.80 |
Low | 11.80 |
Bid | 11.30 |
Offer | 11.70 |
Previous close | 12.00 |
Average volume | 1.10 |
---|---|
Shares outstanding | 21.16m |
Free float | 19.87m |
P/E (TTM) | -- |
Market cap | 261.70m USD |
EPS (TTM) | -6.56 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 07:03 BST.
More ▼